18 Months for a Terbutaline Inhaler: When a Doping Control Form Could Not Save a 17-Year-Old

In February, a laboratory in India returned a positive result. The substance found was terbutaline. The sample belonged to a 17-year-old swimmer. He has not been formally named, because he is a minor and anti-doping rules do not permit the publication of a minor's identity. I read that report on an Indian sports page, right next to the spreadsheet of 247 V.League injury cases I built over three months after my 2026 mistake with Nguyen Van Quyet.

Some injuries do not sit in the tendon. They sit in the way we look.

There is no torn tendon in this case. There is no ultrasound image to read. But the structure is one I have met many times: a body placed in a situation it does not control, then judged by a hard number. The boy declared the substance on his doping control form. He still received an 18-month suspension.

The facts, in a few lines

The Swimming Federation of India withdrew his name from the Commonwealth Games roster and later from the Asian Games roster. He was removed from India's swimming team and suspended for 18 months. He had qualified to race two events at the Games taking place in Japan this month.

An expedited hearing took place last week. The national swimming federation hoped the case would be dropped so he could return to the water. That did not happen.

The Times of India and other domestic outlets report that the suspended swimmer's twin brother remains on the Asian Games team. Only one swimmer fits that description. Both brothers appear to have represented India internationally at junior meets, though results reporting often confuses the two similar names, making it hard to isolate their results.

According to the Times of India, he suffered smoke inhalation and took the prescription with a doctor's approval, but did not properly obtain a therapeutic use exemption. He listed the substance on his doping control form.

The mechanism: terbutaline is not an obscure substance

Terbutaline is a beta-2 agonist. This class of drugs opens the airways and is commonly prescribed for patients with asthma, emphysema, bronchitis and other lung diseases, per the Mayo Clinic. In the pharmaceutical market it sits among inhalers so familiar that any respiratory physician can prescribe one in half a minute.

The problem lies elsewhere. The same molecule, entering the body through inhalation to open an airway, is medicine. Entering at a dose and moment sufficient to create an advantage, it is a prohibited substance. An anti-doping authority cannot read the intent of the person inhaling. It can only read concentration. That is why a mechanism called a therapeutic use exemption exists.

Therapeutic use exemption is what I call a paper shield. It does not make the substance vanish from the urine sample. It only records in advance: this substance will appear, here is the medical reason, here is the dose, here is the responsible physician. When the paper shield is not signed through the proper process, the sample still returns positive, and the athlete stands alone before the panel.

Data is only dry bone; it needs context to become blood vessels.

Read only the line "positive for terbutaline" and you would assume a sophisticated case of cheating. Set it beside smoke inhalation, a prescription signed off by a doctor, and the boy's own declaration of the substance, and the picture changes colour entirely. A cheat hides. A 17-year-old declared.

The scale of sanction and an 18-month gap

The standard sanction for an anti-doping rule violation is four years. That can be reduced to two years if the panel believes the athlete did not intentionally dope. Further reductions follow depending on how convincingly the athlete demonstrates a reasonable explanation for unintentional doping.

Two years. Then below two years. Finally 18 months.

I once built a Load Decay Index to measure whether a player returning after more than 45 days off carried 2.3 times the risk of a muscle injury. That model measured risk to a body. It could not measure risk to a career. An 18-month suspension for a 17-year-old is not 18 months of rest. It is 18 months stripped from the most important physical development cycle of a lifetime, and removal from competition at precisely the stage when technical growth peaks.

Based on my experience following matches and injury cases, I always split the impact of an event into two layers: tissue and system. The tissue layer here is a lung damaged by smoke. The system layer is an entire administrative apparatus deciding that the paperwork was insufficient, so punishment must follow.

One detail made me pause longer than the rest of the report. The boy inhaled the drug because of smoke inhalation. Not because he wanted to go faster over 200 metres. He inhaled in order to breathe.

The counter-angle: India leads a table nobody wants

India is the most populous country in the world. India is not a global sporting superpower. At the 2026 Summer Olympic Games the country won six medals, with no golds. Yet in recent years India has consistently led the world in anti-doping violations.

Placed side by side, those two facts create a paradox I think few people bother to unpick properly. A country not strong enough to compete for medals at world level sits at the top of the field most rigorously policed by international governing bodies.

There are two readings. The first: India's system is loose, its athletes poorly educated, so violations are many. The second: India's system is transparent. A country that publishes its full count of violations will always top the table, while places that hide better stay silent.

I do not have enough data to settle it. And I accept that, after the lesson of the 2026 World Cup, when I wrote three pieces with three contradictory conclusions on high-intensity pressing and my editor could barely publish any of them. Too curious to stop digging, too analytical to close — that is my occupational disease. This time, though, I choose to slow down.

What I will assert, under current observation conditions, is the gap between knowledge and responsibility. A 17-year-old in a country where sports medicine support is thin must personally remember that a treating doctor's prescription does not equal an anti-doping authority's exemption. Those sit at two different administrative levels, signed by two different kinds of people, with no automatic bridge between them.

VAR did not kill football. It only exposed our fear of mistakes. Doping has not killed sport either. It has exposed the fact that we built a rulebook players must understand better than they play.

The twin factor: a natural experiment nobody designed

Two twin brothers, both swimmers, both having represented India at junior international meets, with names so similar that result sheets confuse them. One is suspended. One remains on the Asian Games roster.

In injury research I am always looking for a control pair. Identical twins are the best control nature gives away for free. Put two of them side by side and you cancel the genetic variable, seeing clearly the contribution of environment, training and the administrative system around them.

Here, two nearly identical bodies. One preparing to compete. One sitting out. The difference is not in the deltoid, not in lung capacity, not in stroke rate. The difference is on a piece of paper.

Every injury is a story the body tries to tell us. But in some cases the body says nothing at all. The piece of paper speaks instead.

And here is the point I want readers to carry away. When an anti-doping system processes a minor, it is processing a subject whose brain has not finished developing its long-term risk assessment. The prefrontal cortex is still growing. The capacity to defend oneself against a complex administrative process is therefore lower than in an adult. The duty of education belongs to the federation, not to the boy. An 18-month suspension lands on the boy. But the gap sits in the federation's own training system, where someone should have checked the therapeutic use exemption before signing the entry list.

What remains after the suspension

The pandemic season taught me that data lies but never forgets. The table showing a 41% rise in hamstring injuries across six European leagues when football returned will not erase itself. It sits there, waiting for the next reader.

This terbutaline case will sit in some table too. One row: male, 17, swimming, terbutaline, 18 months. That row is administratively correct. It cannot say that the boy inhaled to breathe, that he declared it, and that he was still suspended until the junior meets rolled past without him.

Before reading the next doping ruling, I want to remind myself of this. Ask at which level the therapeutic use exemption was signed, by whom, and why nobody checked it before a 17-year-old stepped onto the starting block. If the answer is "nobody", then the 18-month sanction repairs nothing. It only transfers the fault from the system onto one body.

And next time, when another child inhales smoke, takes a prescribed inhaler and forgets one piece of paper, we will have another row of data that is correct administratively and meaningless humanly.